Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2011

Feb 17, 2011

32853_dirs_2011-02-17_d12a68d1-9172-497c-ad67-bb767123ed0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-02-15

Reporting Person: Worthington Gajus Vincent (President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-15 Common Stock X 514 Acquired 375160.00 Indirect
2011-02-15 Common Stock F 1 $13.50 Disposed 375159.00 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-15 Series E-1 Preferred Warrant (Right to Buy) $0.02 X 515 Disposed Common Stock (515) Indirect

Footnotes

F1: Represents shares of Common Stock issued upon the exercise and subsequent conversion of a Warrant to purchase shares of Series E-1 Preferred Stock and has no expiration date.

F2: Not applicable.

F3: Gajus V. Worthington and Jami A. Worthington as TTEEs of the Worthington Family Trust UAD dated March 6, 2007 are the record holder of the securities reported.

F4: Each share of Series E-1 Preferred Stock automatically converted into one share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offering (the "Closing").

F5: The warrant was automatically net exercised immediately prior to the Closing.